Despite its continued dominance over all other coronavirus strains in the United States, Omicron subvariant XBB.1.5 appears to be plateauing. According to estimates provided by the Centers for Disease Control and Prevention, the subvariant was accountable for approximately ninety percent of all new infections this week. That is roughly the same as the previous week and approximately 2 percentage points higher than it was two weeks ago.
The growth of XBB.1.5 in March is significantly lower than the growth that occurred in February, when it increased from 62% of cases to 82%. The strain that is highly transmissible is also the most well-known in the world and the only one that has grown significantly. Covid cases in the U.S. keep on declining. Despite this, CDC data indicate that nearly 30% of counties in the United States are experiencing a “high” level of COVID-19 transmission.
The Biden administration reportedly intends to disband the White House COVID-19 response team in May, as the majority of COVID-19 factors are trending in a positive direction. Additionally, the Biden administration plans to end two COVID-19 emergency declarations on May 11. These actions are the most significant indications to date that the Biden administration is prepared to put the pandemic behind it.
However, early recipients of the updated COVID-19 booster shot have been pleading with the Biden administration to allow another shot before possibly switching to an annual vaccination strategy beginning in the fall.
This week, it was reported that the Food and Drug Administration is considering approving a second omicron-specific booster shot for people 65 and older or with weakened immune systems. This gave that group a glimmer of hope.
According to reports, they trust that improving on the COVID-19 immunization routine not long from now will prompt the inoculation of additional people before very long as we figure out how to live close by SARS-CoV-2 – possibly lessening serious results, including hospitalization and demise, alluding to the infection that causes Coronavirus by its logical name.
According to a Spokesperson, they will accept any decision on additional updated boosters upon the data. Importantly, individuals who have not yet received a current (bivalent) booster are encouraged to discuss the possibility of receiving one with their doctor.
